Complete remission induced by high-dose erythropoietin and granulocyte colony-stimulating factor in acute erythroleukemia (AML-M6 with maturation)

Haematologica

Volumn 87, Issue 11, 2002, Pages 1225-1227

  Camera, Andrea ^a   Volpicelli, Mario ^a   Rosario Villa, Maria ^a   Risitano, Antonio M ^a   Rossi, Marco ^a   Rotoli, Bruno ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Erythroleukemia; Palliative treatment; Recombinant erythropoietin

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; CYTOTOXIC AGENT; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLAST CELL; CANCER RECURRENCE; CASE REPORT; DRUG EFFICACY; DRUG MEGADOSE; ERYTHROID CELL; ERYTHROLEUKEMIA; HUMAN; HYPERVISCOSITY SYNDROME; LEUKEMIA REMISSION; MALE; PROGNOSIS; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ERYTHROPOIETIN; FATAL OUTCOME; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MALE; REMISSION INDUCTION;

EID: 0036856276     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Anonymous. A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. Italian Cooperative Study Group for rHuEpo in Myelodysplastic Syndromes. Br J Haematol 1998; 103:1070-4.
2. Cascinu S, Fedeli A, Del Ferro E, Luzi Fedeli S, Catalano G. Recombinant human erythropoietin treatment in cisplatin-associated anemia: A randomized, double-blind trial with placebo. J Clin Oncol 1994; 12:1058-62.
3. Osterborg A, Boogaerts MA, Cimino R, Essers U, Holowiecki J, Juliusson G, et al. Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma: A randomized multicenter study. Blood 1996; 87:2675-82.
4. Negrin RS, Stein R, Doherty K, Cornwell J, Vardiman J, Krantz S, et al. Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: Evidence for in vivo synergy. Blood 1996; 87:4076-81.
5. Thompson JA, Gilliland DG, Prchal JT, Bennett JM, Larholt K, Nelson RA, et al. Effect of recombinant human erythropoietin combined with granulocyte-macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. Blood 2000; 95:1175-9.
6. Mazzella FM, Kowal-Vern A, Shrit MA, Wibovo AL, Rector JT, Cotelingam JD, et al. Acute erythroleukemia: Evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis. Am J Clin Pathol 1998; 110:590-8.
7. Estey EH. How I treat older patients with AML. Blood 2000; 96:1670-3.
8. Miyazaki E, Kohgo Y, Hirayama M, Kawanishi J, Kato J, Sakamaki S, et al. Remission after erythropoietin administration for erythroleukemia: A case study. Blood 1993; 82:1378-80.
9. , Takamatsu Y, Miyamoto T, Iwasaky H, Makino S,Tamura K. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection: A case report and review of the literature. Acta Haematologica 1998; 99:224-30.
10. Ferrara F, Di Noto R, Viola A, Russo C, Boccuni P, Costantini S, et al. Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G-CSF: Flow cytometric analysis of in vivo and in vitro effects on cell maturation. Br J Haematol 1999; 106:520-3.